Bispecific Antibodies market Size, Share, Trends by 2035

Given the recent approval of a number of bispecific antibodies and several ongoing R&D efforts focused on evaluating the potential of such candidates against various disease indications, this sector of the pharmaceutic industry has garnered significant interest of stakeholder

Roots Analysis has announced the addition of “Bispecific Antibodies Market, 2023-2035” report to its list of offerings.

The report features an extensive study of the current market landscape, offering an informed opinion on the likely evolution of the market for such therapeutics over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:
 An executive summary of the key insights captured during our research
 A brief introduction to bispecific antibodies, highlighting their historical background, as well as information on their structure, different types available, unique antibody formats, mechanisms of action of various drugs and their applications
 A detailed review of the market landscape of over 220 bispecific antibodies that are either approved or being evaluated in different stages of clinical development
 An in-depth assessment of the market landscape of over 180 bispecific antibodies that are currently being evaluated in preclinical studies
 An insightful analysis, highlighting the contemporary market trends in the bispecific antibody therapeutics domain, through six different graphical representations
 A detailed assessment of over 80 technology platforms being developed / used by various drug developers for the production of bispecific antibody therapeutics
 An in-depth analysis of big pharma players engaged in this domain, featuring insightful spider web analyses and heat map analyses
 Elaborate profiles of prominent drug developers engaged in the development of bispecific antibodies, featuring a brief overview of the company, along with information on year of establishment, number of employees, location of headquarters, key members of the executive team, financial details / information (if available), drug portfolio, recent developments and an informed future outlook
 An insightful analysis of various partnerships inked between stakeholders engaged within the bispecific antibody therapeutics domain, during the period 2016-2023
 A review on the key steps involved and challenges associated with the manufacturing of bispecific antibodies, along with information on various contract manufacturing organizations (CMOs) and contract research organizations (CROs) engaged in this domain
 An in-depth analysis of ongoing and planned clinical trial studies related to bispecific antibody therapeutics, which were registered till April 2023
 A review of regulatory guidelines issued by the ICH, WHO and FDA for the development of bispecific antibodies. In addition, it provides details related to the responses of various pharmaceutical industries to the FDA guidelines
 A review of different channels used for promoting marketed bispecific antibodies, elaborating on the various promotional strategies being adopted by developers of two approved bispecific antibodies (chosen based on their popularity in this domain), namely Blincyto™ and Hemlibra®
 A discussion on important, industry-specific trends, key market drivers and challenges, under a SWOT framework, featuring a qualitative Harvey ball analysis highlighting the relative impact of each SWOT parameter on the overall market
 A comprehensive market forecast analysis, including future sales projections of bispecific antibodies that are either marketed or under phase III of clinical development, till the year 2035, presenting a detailed market segmentation on various segments:

 Therapeutic Area
 Autoimmune Disorders
 Genetic Disorders
 Hematological Malignancies
 Ophthalmic Disorders
 Skin Cancers
 Solid Tumors

 Mechanism of Action
 Cytokines Retargeting / Neutralization
 Dual Ligands Blocking
 Resistance Factors Co-targeting
 Targeting Tumor Angiogenesis
 T-Cell Retargeting / Activation
 Others

 Target Antigen
 C5-Albumin
 CD20 x CD3
 CD3 x BCMA
 CD3 x CD19
 EGFR x cMET
 EpCAM x CD3
 Factor IXa x Factor X
 gp100 x CD3
 HER2 x HER2
 PD-1 x CTLA-4
 PD-L1 x TGFβ
 TNF-α x HSA
 VEGF x DLL4
 VEGF-A x ANG2

 Antibody Format
 Asymmetric
 Fragments

 Key Players
 Akeso Biopharma
 Alexion
 Amgen
 Genmab
 Immunocore
 Janssen Research & Development
 Linton Pharm
 Merck
 OncXerna Therapeutics
 Pfizer
 Roche
 Taisho Pharmaceutical
 Zymeworks

 Key Geographical Regions
 Asia
 Europe
 North America
 Rest of the World

Key companies covered in the report
 Akeso Biopharma
 Alphamab Oncology
 Amgen
 Merck
 Regeneron
 Roche
 Xencor

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/view_documen

Learn from experts: do you know about these emerging industry trends?
Top 10 Companies Offering Oral Solid Dosage Manufacturing Services
Top 10 Quantum Computing Companies Transforming Drug Discovery

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Connect with our Roots Analysis Consulting team: For your custom research exclusive best-in-class quality projects

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#bispecificantibodiesmarket #bispecificantibodiesmarketsize #bispecificantibody #bispecificantibodies #approvedbispecificantibodies

Fill Finish Biopharmaceuticals market, Industry Analysis, and Forecast to 2035

Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products.

This evident surge in the demand for biologics fill and finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities.

The financial opportunity within the biologics fill finish services market has been analysed across the following segments:

 Type of Packaging Container
 Ampoules
 Cartridges
 Syringes
 Vials

 Type of Biologic
 Antibodies
 Cell Therapies
 Gene Therapies
 Oligonucleotides
 Proteins / Peptides
 Vaccines
 Others

 Therapeutic Area
 Oncological Disorders
 Autoimmune Disorders
 Infectious Diseases
 Cardiovascular Disorders
 Other Disorders

 Scale of Operation
 Preclinical / Clinical
 Commercial

 Company Size
 Large
 Mid-sized
 Small

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:
 AbbVie Contract Manufacturing
 Asymchem
 BioReliance
 Boehringer Ingelheim BioXcellence
 Catalent Biologics
 Charles River Laboratories
 Fareva
 Fresenius Kabi
 Glaxo SmithKline
 Hetero Drugs
 Intas Pharmaceuticals
 Lonza
 Patheon
 Pierre Fabre
 Recipharm
 Samsun Biologics
 Syngene
 Takara Bio
 Wacker Biotech
 WuXi AppTec
 WuXi Biologics

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Biologics Fill / Finish Service Providers: Market Landscape

5. Company Competitiveness Analysis

6. Biologics Fill / Finish Service Providers in North America

7. Biologics Fill / Finish Service Providers in Europe

8. Biologics Fill / Finish Service Providers in Asia-Pacific

9. Recent Partnerships

10. Recent Expansions

11. Capacity Analysis

12. Demand Analysis

13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish

14. Regional Capability Assessment

15. Biologics Fill Finish Market Sizing and Opportunity Analysis

16. Future Growth Opportunities

17. Case Study: Robotic Systems in Fill / Finish Operations

18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish

19. Concluding Remarks

20. Executive Insights

21. Appendix 1: Tabulated Data

22. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/view_documen

News article
women's digital health market

Learn from experts: do you know about these emerging industry trends?
Bioavailability Enhancement Technologies
TIL Therapies: A New Paradigm in Cancer Treatment

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#fillfinishbiopharmaceuticalsmarketgrowth#fillfinishbiopharmaceuticalsmarkettrends#fillfinishmarket#fillfinishmanufacturingmarket#fillfinishservicemarket

Medical Device Coating market Analysis and Trends by 2023-2035

Roots Analysis has done a detailed study on “Medical Device Coatings and Surface Modification Technologies Market, 2023-2035”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities

Key Market Insights
 Currently, more than 85 companies provide medical coatings that serve a wide array of functions and are compatible with a diverse array of substrate materials; majority of such players have entered this domain post 2,000
 Companies engaged in this industry provide a wide range of coating materials for different types of medical devices; of these, close to 70% of the coatings are being offered for medical implants
 In order to gain an edge in this competitive industry, coating providers are continuously undertaking initiatives to upgrade their existing material offerings and coating solutions for medical devices
 Presently, more than 115 surface modification technologies and coating solutions are being offered by players to enhance the surface functions and resistance of medical devices
 The current market landscape is highly fragmented, featuring the presence of both new entrants and established players across key geographical regions; majority of the players are based in the US
 In pursuit of gaining a competitive edge, developers are making an active effort to incorporate advanced technologies into their respective portfolios of coatings / technologies and comply with evolving industry needs
 The rising interest of stakeholders in surface modification of medical devices and coating solutions is reflected by the increasing number of partnerships established between various industry and non-industry players
 Built on our intellectual capital, we have proposed a proprietary framework that can be applied to strengthen the strategic planning processes and risk management within the industry
 With the rising demand for medical device coating solutions and services, the affiliated market for service providers is expected to grow at a steady annualized rate of 7.7% over the coming decade
 The opportunity associated with the medical coatings market is expected to be well distributed among players of different company sizes, with majority of the revenue being coming in from developed regions.

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Medical Device Coatings
3.3. Surface Modification Technologies
3.4. Future Perspectives

4. MEDICAL DEVICE COATING PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Medical Device Coatings Providers: Overall Market Landscape

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Medical Device Coatings Providers: Company Competitiveness Analysis

6. SURFACE MODIFICATION TECHNOLOGIES AND COATING SOLUTIONS: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Surface Modification Technologies and Coating Solutions: Overall Market Landscape
6.3. Medical Device Surface Modification Technologies and Coating Solutions: Developer Landscape

7. PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis

8. MEDICAL DEVICE COATING PROVIDERS: COMPANY PROFILES
8.1. Chapter Overview
8.2. Advanced Coating
8.3. Biocoat
8.4. Evonik Health Care
8.5. Formacoat
8.6. Harland Medical Systems
8.7. Para-Coat Technologies
8.8. Specialty Coating Systems
8.9. SurModics
8.10. TUA Systems

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. List of Partnerships and Collaborations

10. MEDICAL DEVICE COATING PROVIDERS: PESTLE ANALYSIS
10.1. Chapter Overview
10.2. Methodology
10.3. Key Factors
10.4. PESTLE Analysis: Medical Device Coating Providers
10.5. Concluding Remarks

11. MARKET FORECAST
11.1. Chapter Overview
11.2. Key Assumptions and Forecast Methodology
11.3. Global Medical Device Coatings Market, 2023-2035

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS
13.1. Chapter Overview
13.2. Biocoat
13.3. N8 Medical
13.4. VaporTech

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/medical-devi

Learn from experts: do you know about these emerging industry trends?
Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
Digital Therapies: The “Digital Pills” of current generation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#medicaldevicecoatingmarket #medicaldevicecoatingmarketsize #medicaldevicecoating #medicalcoatingsmarket #medicalcoatingcompanies

Automated Liquid Handling Systems market Analysis and Trends by 2023-2035

The growing demand for greater accuracy, increased flexibility and reduced errors has prompted biopharmaceutical industry stakeholders to consider shifting from manually operated systems to automated systems for efficient liquid handling

Roots Analysis is pleased to announce the publication of its recent study, titled, “Automated Liquid Handling Systems Market, 2023-2035.”

The report features an extensive study of the current market landscape, market size and future potential of the liquid handling automation systems market, over the forecast period. It highlights the efforts of various stakeholders engaged in this rapidly emerging segment of the process equipment industry. Key takeaways of the automated liquid handling systems market includes:
 An executive summary of the insights captured during our research.
 A general overview of liquid handling systems, along with comparison between manual, semi-automated and automated liquid handling systems.
 A detailed assessment of the current market landscape of automated pipetting systems, based on several relevant parameters.
 A detailed competitiveness analysis of automated pipetting system providers based on several relevant parameters
 Elaborate profiles of key companies (shortlisted based on a proprietary criterion) engaged in the manufacturing of automated pipetting systems across North America, Europe and Asia-Pacific and rest of the world.
 A detailed assessment of the current market landscape of automated microplate washers, based on several relevant parameters.
 A detailed competitiveness analysis of automated microplate washer providers based on several relevant parameters.
 Elaborate profiles of key companies (shortlisted based on a proprietary criterion) engaged in the manufacturing of automated microplate washers across North America, Europe and Asia-Pacific and rest of the world.
 A detailed analysis of partnerships inked between stakeholders engaged in this industry since 2018.
 An in-depth analysis of various patents that have been filed / granted related to automated liquid handling systems since 2018.
 A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Automated Pipetting Systems Market
 Pipetting Technology
 Contact Technology
 Air Displacement Technology
 Piston / Positive Displacement Technology
 Acoustic Technology
 Free-jet Technology

 Modality
 Fixed Tips
 Disposable Tips

 Type of Instrument
 Standalone
 Individual Benchtop Workstation
 Multi Instrument Systems
 Others

 Applications
 Serial Dilution
 Plate Replication
 PCR / qPCR Setup
 Plate Reformatting
 High-throughput Screening
 Whole Genome Amplification
 Cell Culture
 Other Applications

 End User
 Biotechnology and Pharmaceutical Companies
 Academic and Government Research Institutes
 Hospitals and Diagnostic Centers
 Other End Users

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

Automated Microplate Washers Market
 Washing Technology
 Ultrasonic Technology
 Acoustic Technology
 Centrifugal Technology

 Application
 ELISA
 Cell-based Assays
 Bead Washing
 Other Applications

 End-user
 Biotechnology and Pharmaceutical Companies
 Academic and Government Research Institutes
 Hospitals and Diagnostic Centers
 Other End Users

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America


Key companies covered in the report
 Agilent Technologies
 Beckman Coulter Life Sciences
 Eppendorf
 Hamilton Robotics
 MyGenostics
 Tecan
 Thermo Fisher Scientific

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/automated-li

News article
Global Cell Free Expression Market

Learn from experts: do you know about these emerging industry trends?
Top 10 Cannabis Testing Labs Supporting North America's Medical Marijuana Industry
Top 10 Companies Offering Oral Solid Dosage Manufacturing Services

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#automatedliquidhandlingsystemsmarket #automatedliquidhandlingsystemsmarketsize #automatedliquidhandling #automatedliquidhandler #hamiltonliquidhandler

Cell Free Expression market, Size and Share by 2035

Considering the benefits offered by cell free expression, including low cost of production, shortened production timelines and better control over the reaction environment, the adoption of cell free systems has increased over the years.

Driven by the ongoing pace of innovation and growing adoption of cell free systems in the production of biomolecules, the global cell free expression market is anticipated to grow at a healthy pace in the foreseen future.

The financial opportunity within the cell free market is analyzed across the following segments:

 Type of Cell Free System
 Crude Cell Lysate-based Systems
 Reconstituted Systems

 Type of Host Organism
 Microbial Cell Free Expression System
 Mammalian Cell Free Expression Systems
 Plant-based Cell Free Expression Systems
 Other Cell Free Expression Systems

 Type of Expression Method
 Coupled Transcription and Translation Method
 Translation Method

 End-User
 Pharmaceutical and Biotechnology Companies
 Academic and Research Institutes
 Other End-Users

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Rest of the World

The Cell Free Systems: Cell Free Expression Kits and Service Providers, 2023-2035 report features the following companies, which we identified to be key players in this domain:
 BioLinker
 biotechrabbit
 CellFree Sciences
 Creative Biolabs
 CUSABIO
 Daicel Arbor Biosciences
 LenioBio
 Promega
 Thermo Fisher Scientific
 Touchlight

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape: Cell Free Expression Service Providers

5. Market Landscape: Cell Free Expression Kits

6. Cell Free Expression Service Providers: Company Competitiveness Analysis

7. Cell Free Expression Kits: Product Competitiveness Analysis

8. Company Profiles: Cell Free Expression Service Providers

9. Company Profiles: Cell Free Expression Kit Providers

10. Partnerships And Collaborations

11. Funding And Investment Analysis

12. Patent Analysis

13. Market Forecast And Opportunity Analysis

16. Appendix 1: Tabulated Data

17. Appendix 2: List Of Companies And Organizations

For additional details, please visit https://www.rootsanalysis.com/....reports/cell-free-ex

Learn from experts: do you know about these emerging industry trends?
Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities
Investment Opportunities in Women’s Digital Health

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#cellfreeexpressionmarkettrends #cellfreeexpressionmarketgrowth #cellfreeproteinexpressionsystem #biomanufacturing #cellfreeexpressionsystem